Twitter | Search | |
AstraZeneca
We're a global, science-led biopharmaceutical company & our innovative medicines are used by millions of patients worldwide. We believe in what science can do.
4,787
Tweets
1,075
Following
135,660
Followers
Tweets
AstraZeneca 3h
We are so proud of our team winning the award for best overall company IR!
Reply Retweet Like
AstraZeneca 10h
Investigations led from our graduate programme have delivered the first predominantly RNA-free guide molecule capable of directing Cas9 gene editing. Learn more:
Reply Retweet Like
AstraZeneca retweeted
IChemE 12h
“In light of Brexit we must preserve an EU and UK trading relationship to advance the pharma sector - Lisa Anson - Parliamentary & Scientific Committee Annual Lunch
Reply Retweet Like
AstraZeneca retweeted
ABPI 18h
Replying to @EMA_News
Yesterday it was announced that the European Medicines Agency () will move from London to Amsterdam. View our CEOs response and his call for urgent progress 2/8
Reply Retweet Like
AstraZeneca 15h
Scientists in our IMED Biotech Unit have developed a novel “guide” molecule that is capable of directing the Cas9 nuclease to sites of precise genome editing. Find out how this will drive us towards enhanced genome editing systems of the future:
Reply Retweet Like
AstraZeneca Nov 20
We were delighted to welcome to our future strategic science R&D centre and Global HQ in Cambridge to talk about the excellence of UK science and how the industrial strategy can help.
Reply Retweet Like
AstraZeneca Nov 20
Thank you to everyone for sharing on . Enjoy our highlights from .
Reply Retweet Like
AstraZeneca retweeted
George Pippas Nov 16
visited Astra Zeneca today and was shown the ongoing building work. Very impressive building !
Reply Retweet Like
AstraZeneca Nov 18
Thank you ! It was a privilege to join the discussion on the latest advances in
Reply Retweet Like
AstraZeneca Nov 17
Brain metastases are a common complication of and can be disabling, often proving difficult to treat
Reply Retweet Like
AstraZeneca Nov 17
The EGFR mutation is present in 30-40% of Asian patients with . Detection can help determine treatment
Reply Retweet Like
AstraZeneca Nov 17
Eosinophils are biological effector cells in approximately 50% of patients
Reply Retweet Like
AstraZeneca Nov 17
Reply Retweet Like
AstraZeneca Nov 17
We welcome the support for the infrastructure investment as acceleration of Cambs South station is critical for UK life sciences growth. Read the report here:
Reply Retweet Like
AstraZeneca Nov 16
We are committed to putting patients first and exploring new treatment options in areas with unmet need
Reply Retweet Like
AstraZeneca Nov 16
Over 50% of global cases occur in Asia. We are looking forward to sharing our latest research at
Reply Retweet Like
AstraZeneca Nov 16
Patient engagement is a crucial part of research as we progress towards an earlier diagnosis
Reply Retweet Like
AstraZeneca Nov 16
asthma is one of several possible phenotypes and can be severe
Reply Retweet Like
AstraZeneca retweeted
Maria Belvisi Nov 16
Celebrating 50 year history and a bright future!
Reply Retweet Like
AstraZeneca Nov 16
10% of patients have , a type of asthma that is difficult to control even with treatments
Reply Retweet Like